Martinez S, Sentis S, Poulard C, Tredan O, Le Romancer M
Int J Mol Sci. 2024; 25(16).
PMID: 39201539
PMC: 11354362.
DOI: 10.3390/ijms25168854.
Wang Y, Zuo D, Huang Z, Qiu Y, Wu Z, Liu S
Int J Mol Sci. 2024; 25(13).
PMID: 39000273
PMC: 11240942.
DOI: 10.3390/ijms25137165.
Yuan L, Meng Y, Xiang J
Dig Dis Sci. 2024; 69(8):2841-2855.
PMID: 38816600
DOI: 10.1007/s10620-024-08473-y.
Ding H, Tong J, Lin H, Ping F, Yao T, Ye Z
Aging (Albany NY). 2024; 16(9):8070-8085.
PMID: 38728249
PMC: 11132013.
DOI: 10.18632/aging.205805.
Potapenko A, Davidson J, Lee A, Laird A
Biochem J. 2024; 481(6):461-480.
PMID: 38497605
PMC: 11088879.
DOI: 10.1042/BCJ20240017.
SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner.
Nagasaka M, Inoue Y, Nagao Y, Miyajima C, Morishita D, Aoki H
Sci Rep. 2023; 13(1):22877.
PMID: 38129484
PMC: 10739863.
DOI: 10.1038/s41598-023-49961-x.
Therapeutic Targeting of Krüppel-Like Factor 4 and Its Pharmacological Potential in Parkinson's Disease: a Comprehensive Review.
Zamanian M, Golmohammadi M, Amin R, Bustani G, Romero-Parra R, Zabibah R
Mol Neurobiol. 2023; 61(6):3596-3606.
PMID: 37996730
PMC: 11087351.
DOI: 10.1007/s12035-023-03800-2.
KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT.
Zhang X, Wang W, Lu C, Zhang H
Oncol Rep. 2023; 50(6).
PMID: 37937607
PMC: 10652240.
DOI: 10.3892/or.2023.8659.
Pioneer factors in viral infection.
Neugebauer E, Bastidas-Quintero A, Weidl D, Full F
Front Immunol. 2023; 14:1286617.
PMID: 37876935
PMC: 10591220.
DOI: 10.3389/fimmu.2023.1286617.
Amplifications and Metabolic Rewiring in Neuroblastoma.
Pouliou M, Koutsi M, Champezou L, Giannopoulou A, Vatsellas G, Piperi C
Cancers (Basel). 2023; 15(19).
PMID: 37835497
PMC: 10571721.
DOI: 10.3390/cancers15194803.
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors.
He R, Weng Z, Liu Y, Li B, Wang W, Meng W
Stem Cell Rev Rep. 2023; 19(8):2557-2575.
PMID: 37755647
PMC: 10661832.
DOI: 10.1007/s12015-023-10633-y.
Expression of stem cell markers SALL4, LIN28A, and KLF4 in ameloblastoma.
de Albuquerque Dias R, Balbinot K, da Silva Kataoka M, de Melo Alves Junior S, de Jesus Viana Pinheiro J
Diagn Pathol. 2023; 18(1):92.
PMID: 37559082
PMC: 10413759.
DOI: 10.1186/s13000-023-01379-9.
KLF4 transcription factor in tumorigenesis.
He Z, He J, Xie K
Cell Death Discov. 2023; 9(1):118.
PMID: 37031197
PMC: 10082813.
DOI: 10.1038/s41420-023-01416-y.
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy.
Taib N, Merhi M, Inchakalody V, Mestiri S, Hydrose S, Makni-Maalej K
J Transl Med. 2023; 21(1):235.
PMID: 37004094
PMC: 10067322.
DOI: 10.1186/s12967-023-04073-y.
Corneal epithelial development and homeostasis.
Swamynathan S, Swamynathan S
Differentiation. 2023; 132:4-14.
PMID: 36870804
PMC: 10363238.
DOI: 10.1016/j.diff.2023.02.002.
New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.
Zeng L, Zhu Y, Moreno C, Wan Y
Semin Cancer Biol. 2023; 90:29-44.
PMID: 36806560
PMC: 10023514.
DOI: 10.1016/j.semcancer.2023.02.003.
MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4.
Wang R, Yu W, Zhu T, Lin F, Hua C, Ru L
Cancer Sci. 2023; 114(6):2277-2292.
PMID: 36786527
PMC: 10236612.
DOI: 10.1111/cas.15757.
Control of protein stability by post-translational modifications.
Lee J, Hammaren H, Savitski M, Baek S
Nat Commun. 2023; 14(1):201.
PMID: 36639369
PMC: 9839724.
DOI: 10.1038/s41467-023-35795-8.
Stages of preadipocyte differentiation: biomarkers and pathways for extracellular structural remodeling.
Hu Z, Liu Y, Yao Z, Chen L, Wang G, Liu X
Hereditas. 2022; 159(1):47.
PMID: 36572937
PMC: 9793557.
DOI: 10.1186/s41065-022-00261-w.
Kruppel-like Factors in Skeletal Physiology and Pathologies.
Abe M, Saeki N, Ikeda Y, Ohba S
Int J Mol Sci. 2022; 23(23).
PMID: 36499521
PMC: 9741390.
DOI: 10.3390/ijms232315174.